Disclosures for "RNAi Therapeutics for hATTR Amyloidosis: A Comprehensive Single Arm Meta-Analysis of Clinical Outcomes and Treatment Efficacy"
-
Mr. Vargas Rojas has nothing to disclose.
-
Mr. Lira Castañeda has nothing to disclose.
-
Mr. Mendoza has nothing to disclose.
-
Dr. LLERENA VARGAS has nothing to disclose.
-
Dr. Morales Acosta has nothing to disclose.
-
Dr. Campos Muñoz has nothing to disclose.
-
Dr. Sanchez has nothing to disclose.
-
Dr. Sanchez Ramirez has nothing to disclose.
-
Miss Esguerra Romano has nothing to disclose.
-
Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Anylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.